Professional Documents
Culture Documents
Full download Advances in Parasitology, Volume 115 Russell Stothard file pdf all chapter on 2024
Full download Advances in Parasitology, Volume 115 Russell Stothard file pdf all chapter on 2024
Russell Stothard
Visit to download the full and correct content document:
https://ebookmass.com/product/advances-in-parasitology-volume-115-russell-stothar
d/
More products digital (pdf, epub, mobi) instant
download maybe you interests ...
https://ebookmass.com/product/advances-in-parasitology-
volume-117-david-rollinson-2/
https://ebookmass.com/product/advances-in-parasitology-
volume-117-david-rollinson/
https://ebookmass.com/product/advances-in-protein-chemistry-and-
structural-biology-volume-115-dna-repair-rossen-donev/
https://ebookmass.com/product/advances-in-ophthalmology-and-
optometry-2022-volume-7-1-advances-volume-7-1-myron-yanoff-md-
editor/
Advances in Ophthalmology and Optometry, 2021 (Volume
6-1) (Advances, Volume 6-1) Myron Yanoff Md (Editor)
https://ebookmass.com/product/advances-in-ophthalmology-and-
optometry-2021-volume-6-1-advances-volume-6-1-myron-yanoff-md-
editor/
https://ebookmass.com/product/advances-in-economic-measurement-a-
volume-in-honour-of-d-s-prasada-rao-duangkamon-chotikapanich/
https://ebookmass.com/product/advances-in-cosmetic-surgery-
volume-2-2019-2019-edition-edition-gregory-h-branham/
https://ebookmass.com/product/understanding-willing-participants-
milgrams-obedience-experiments-and-the-holocaust-volume-1-nestar-
russell/
https://ebookmass.com/product/understanding-willing-participants-
volume-2-milgrams-obedience-experiments-and-the-holocaust-nestar-
russell/
VOLUME ONE HUNDRED AND FIFTEEN
ADVANCES IN
PARASITOLOGY
SERIES EDITOR
D. ROLLINSON J. R. STOTHARD
Life Sciences Department Department of Tropical
The Natural History Museum, Disease Biology
London, United Kingdom Liverpool School of Tropical
d.rollinson@nhm.ac.uk Medicine, Liverpool, United Kingdom
russell.stothard@lstmed.ac.uk
EDITORIAL BOARD
T. J. C. ANDERSON K. KING
Department of Genetics, Texas Department of Zoology,
Biomedical Research Institute, University of Oxford,
San Antonio, TX, United States Oxford, United Kingdom
M. G. BASÁÑEZ M. G. ORTEGA-PIERRES
Professor of Neglected Tropical Professor of the Department of Genetics
Diseases, Department of Infectious and Molecular Biology,
Disease Epidemiology, Faculty of Centro de Investigación y de
Medicine (St Mary’s Campus), Estudios Avanzados IPN,
Imperial College London, Mexico City, Mexico
London, United Kingdom
D. L. SMITH
D. D. BOWMAN Johns Hopkins Malaria Research
Director Cornell CVM MPS—Veterinary Institute & Department of Epidemiology,
Parasitology, Professor of Parasitology, Johns Hopkins Bloomberg School
C4-119 VMC, Dept Micro & Immunol, of Public Health, Baltimore,
CVM Cornell University, Ithaca, MD, United States
NY, United States
R. B. GASSER R. C. A. THOMPSON
Head, WHO Collaborating Centre
Faculty of Veterinary and Agricultural
for the Molecular Epidemiology
Sciences, The University of Melbourne,
of Parasitic Infections, Principal
Parkville, VIC, Australia
Investigator, Environmental
A. L. GRAHAM Biotechnology CRC (EBCRC),
Professor of Ecology & Evolutionary Biology, School of Veterinary and Biomedical
Co-Director of the Global Health Program, Sciences, Murdoch University,
Princeton University, Princeton, Murdoch, WA, Australia
NJ, United States
X.-N. ZHOU
J. KEISER Professor, Director, National Institute of
Head, Helminth Drug Development Unit, Parasitic Diseases,
Department of Medical Parasitology and Chinese Center for Disease Control
Infection Biology, Swiss Tropical and Public and Prevention, Shanghai,
Health Institute, Basel, Switzerland People’s Republic of China
VOLUME ONE HUNDRED AND FIFTEEN
ADVANCES IN
PARASITOLOGY
Edited by
DAVID ROLLINSON
Life Sciences Department
The Natural History Museum,
London, United Kingdom
RUSSELL STOTHARD
Department of Tropical
Disease Biology
Liverpool School of Tropical
Medicine, Liverpool, United Kingdom
Academic Press is an imprint of Elsevier
125 London Wall, London EC2Y 5AS, United Kingdom
The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom
50 Hampshire Street, 5th Floor, Cambridge, MA 02139, United States
525 B Street, Suite 1650, San Diego, CA 92101, United States
No part of this publication may be reproduced or transmitted in any form or by any means, electronic
or mechanical, including photocopying, recording, or any information storage and retrieval system,
without permission in writing from the publisher. Details on how to seek permission, further
information about the Publisher’s permissions policies and our arrangements with organizations such
as the Copyright Clearance Center and the Copyright Licensing Agency, can be found at our website:
www.elsevier.com/permissions.
This book and the individual contributions contained in it are protected under copyright by the
Publisher (other than as may be noted herein).
Notices
Knowledge and best practice in this field are constantly changing. As new research and experience
broaden our understanding, changes in research methods, professional practices, or medical
treatment may become necessary.
Practitioners and researchers must always rely on their own experience and knowledge in evaluating
and using any information, methods, compounds, or experiments described herein. In using such
information or methods they should be mindful of their own safety and the safety of others, including
parties for whom they have a professional responsibility.
To the fullest extent of the law, neither the Publisher nor the authors, contributors, or editors, assume
any liability for any injury and/or damage to persons or property as a matter of products liability,
negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas
contained in the material herein.
ISBN: 978-0-323-98871-1
ISSN: 0065-308X
Contributors vii
1. Introduction 46
2. Terminology and definitions of helminth zoochory 48
3. Features of different vertebrates that affect their ability to disseminate
parasites 49
4. Endozoochory 54
5. Ectozoochory 127
6. Long-distance dispersal 138
7. Conclusion 143
References 146
v
vi Contents
D.J. Bartley
Disease Control, Moredun Research Institute, Penicuik, United Kingdom
Amaya L. Bustinduy
Department of Clinical Research, London School of Hygiene & Tropical Medicine,
London, United Kingdom
J. Charlier
Kreavet, Kruibeke, Belgium
E. Claerebout
Ghent University, Faculty of Veterinary Medicine, Laboratory of Parasitology, Merelbeke,
Belgium
Hermann Feldmeier
Charite University Medicine Berlin, Institute of Microbiology, Infectious Diseases and
Immunology, Berlin, Germany
Margaret Gyapong
Institute of Health Research, University of Health and Allied Sciences, Ho, Ghana
H. Hoste
INRAE, UMR 1225 IHAP INRAE/ENVT, Toulouse University, Toulouse, France
Seke A. Kayuni
Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool,
United Kingdom; MASM Medi Clinics Limited, Blantyre, Malawi
Peter D.C. Leustcher
Centre for Clinical Research, North Denmark Regional Hospital, Hjoerring; Department of
Clinical Medicine, Aalborg University, Aalborg, Denmark
M. Martinez-Valladares
Instituto de Ganaderı́a de Montaña (CSIC-Universidad de León), Departamento de Sanidad
Animal, León, Spain
E.R. Morgan
Institute for Global Food Security, Queen’s University Belfast, Belfast, United Kingdom
Neil J. Morley
School of Biological Sciences, Royal Holloway, University of London, Egham, Surrey,
United Kingdom
Bodo Randriansolo
Association K’OLO VANONA, Antananarivo, Madagascar
L. Rinaldi
University of Naples Federico II, Unit of Parasitology and Parasitic Diseases, Department of
Veterinary Medicine and Animal Production, CREMOPAR, Napoli, Italy
vii
viii Contributors
S. Sotiraki
Veterinary Research Institute, Hellenic Agricultural Organisation ELGO-DIMITRA,
Thessaloniki, Greece
J. Russell Stothard
Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool,
United Kingdom
Amy S. Sturt
Section of Infectious Diseases, Veterans Affairs Palo Alto Health Care System, Palo Alto,
United States
S.M. Thamsborg
Veterinary Parasitology, University of Copenhagen, Frederiksberg C, Denmark
Lisette Van Lieshout
Department of Parasitology, Leiden University Medical Center, Leiden, The Netherlands
G. von Samson-Himmelstjerna
Institute for Parasitology and Tropical Veterinary Medicine, Veterinary Centre for
Resistance Research, Freie Universit€at Berlin, Berlin, Germany
Bonnie L. Webster
Natural History Museum, London, United Kingdom
CHAPTER ONE
Contents
1. Introduction 3
1.1 Selection criteria 3
1.2 Epidemiology and geographical distribution of genital schistosomiasis 3
1.3 Life cycle and transmission 4
1.4 FGS and MGS in less common Schistosoma species 7
1.5 The importance of different hybrids of S. haematobium group species
(including minor species contributing to FGS/MGS) 8
2. Pathogenesis and clinical manifestations 9
2.1 Female genital schistosomiasis (FGS) 9
2.2 Male genital schistosomiasis (MGS) 11
3. Immunology 12
3.1 Vaginal environment in FGS 12
3.2 Immune activation during pregnancy 13
4. Diagnosis of genital schistosomiasis 13
4.1 FGS diagnostics 13
4.2 Molecular diagnostics (nucleic acid amplification tests) 17
4.3 MGS diagnostics 19
4.4 Immunopathology in MGS 20
5. Co-infections and co-morbidities 21
5.1 Human immunodeficiency virus (HIV) 21
5.2 Human papillomavirus (HPV) and FGS 22
6. Immigrants and returned travellers 24
7. Management of FGS and MGS 25
7.1 FGS treatment 25
7.2 Treatment of MGS 28
7.3 Pregnancy 28
8. Disability, stigma and community awareness 29
8.1 Case study: Ghana 29
9. Programme integration 30
10. Conclusions and way forward 33
Acknowledgements 33
References 33
Abstract
The last decades have brought important insight and updates in the diagnosis, man-
agement and immunopathology of female genital schistosomiasis (FGS) and male
genital schistosomiasis (MGS). Despite sharing a common parasitic aetiological agent,
FGS and MGS have typically been studied separately. Infection with Schistosoma
haematobium manifests with gender-specific clinical manifestations and consequences
of infection, albeit having a similar pathogenesis within the human genital tract.
Schistosoma haematobium is a known urinary bladder carcinogen, but its potential caus-
ative role in other types of neoplasia, such as cervical cancer, is not fully understood.
Furthermore, the impact of praziquantel treatment on clinical outcomes remains largely
underexplored, as is the interplay of FGS/MGS with relevant reproductive tract infections
such as HIV and Human Papillomavirus. In non-endemic settings, travel and immigrant
health clinics need better guidance to correctly identify and treat FGS and MGS. Our
review outlines the latest advances and remaining knowledge gaps in FGS and MGS
research. We aim to pave a way forward to formulate more effective control measures
and discuss elimination targets. With a growing community awareness in health prac-
titioners, scientists and epidemiologists, alongside the sufferers from these diseases,
we aspire to witness a new generation of young women and men free from the
downstream disabling manifestations of disease.
An update on female and male genital schistosomiasis 3
1. Introduction
As a neglected tropical disease (NTD), interventions against schisto-
somiasis are featured within the recently outlined WHO 2021–30
Roadmap (WHO, 2021a). Preventive chemotherapy against urogenital
and intestinal schistosomiasis-related morbidity is strongly encouraged and
disease-specific control targets are also defined. However, the detection
and management of disease sequelae within the female and male genital
tracts due to urogenital schistosomiasis, remain unaddressed. In this review,
we seek to highlight the importance and often overlooked connections
between female genital schistosomiasis (FGS) and male genital schistosomi-
asis (MGS), addressing disease-specific needs and challenges in endemic and
non-endemic settings, respectively. Our review presents a comprehensive
summary of the recent published evidence about FGS and MGS to ulti-
mately inform policy makers to support integrative approaches for disease
management.
Fig. 1 Countries with FGS (A) and MGS (B) case reports and studies in S. haematobium
endemic areas in sub-Saharan Africa published to date. Panel (A) is adapted from
Sturt, A.S., Webb, E.L., Francis, S.C., Hayes, R.J., Bustinduy, A., 2020a. Beyond the barrier:
female genital schistosomiasis as a potential risk factor for HIV-1 acquisition. Acta
Trop. 209, 105524 and Panel (B) is adapted from Kayuni, S., Lampiao, F., Makaula, P.,
Juziwelo, L., Lacourse, E.J., Reinhard-Rupp, J., Leutscher, P.D.C., Stothard, J.R., 2019b. A sys-
tematic review with epidemiological update of male genital schistosomiasis (MGS): a call for
integrated case management across the health system in sub-Saharan Africa Parasite
Epidemiol. Control 4, e00077.
Fig. 3 Schistosoma haematobium egg deposition in the female and male genital tracts
causing female and male genital schistosomiasis. Graphic components courtesy of
https://smart.servier.com/.
eggs are released, clinical pathology develops in the vulva and vagina, cervix,
uterus, fallopian tubes and the ovaries (Kjetland et al., 2012) (Fig. 3). All gen-
ital organs may be affected simultaneously, and their dynamics change
through time concurrent with administration with praziquantel, the only
available deworming medication that is active against Schistosoma spp.
(WHO, 2020).
Male genital schistosomiasis (MGS) is a specific chronic manifestation of
schistosomiasis, associated with presence of Schistosoma eggs and pathologies in
male genital fluids and organs of men inhabiting or visiting schistosomiasis-
endemic areas. Of the 54 countries in Africa, only 20 of them have formally
reported FGS and 17 countries have MGS reported cases in the literature
(Kayuni et al., 2019b; Sturt et al., 2020a).